source
- Takeda scraps another phase 2 celiac disease therapy, narrowing pipeline to oneTakeda has dropped another celiac disease therapy from its phase 2 pipeline, leaving the company with just one shot at treating the condition.Fierce Biotech · 8h ago↗ source
- GSK pens $110M biological datasets pact with AI biotech RelationGSK is boosting its AI chops with a new deal worth up to $110 million with Relation.Fierce Biotech · 9h ago↗ source
- Convenience Kit Correction: Argon Medical Issues Correction for Convenience Kits Containing Spectra Medical Device Lidocaine AmpulesArgon Medical is correcting affected convenience kits by removing included Spectra Medical Devices Lidocaine Ampules.fda medwatch · 12h ago